Get started

Momentumstrategy

Momentum play on NQ 45-min via volume-weighted RSIOverview Simple overbought-oversold momentum play using NEXT RSI , which blends volume analysis with momentum. Volume weighing of the algo reduces the lag and improves accuracy over vanilla RSI as volume often precedes price action. This is a contra-trend (momentum exhaustion) scalping strategy - use order management (TP, SL, trailing stops) and do not trade signal to signal (e.g. long-short-long) . Strategy Rules: - NQ Futures, 45min chart - Long Entry when NEXT RSI crosses over 35 - Short Entry when NEXT RSI crosses under 65 Order Management: - Take profit @ +$50 - Stop Loss @ -$50 Prerequisites and set-up: - NEXT RSI configured to 21,3,65,50,35 - NEXT Strategy Visualizer configured to Signal Source: NEXT RSI, LE @ 35, SE @ 65
CME_MINI:NQ1!Education
by ChartVPS
Volume-Weighted Divergence Play on AAPL 10R via NEXT RSINEXT RSI Divergence Play: Key Concepts - NEXT RSI is a low-lag, volume-weighted momentum oscillator that often precedes price action - Divergence play resets at each open (do not count prior session's highs and lows) - Use as you would other divergence strategies: higher price highs, lower NEXT RSI highs = bearish; lower price lows, higher NEXT RSI lows = bullish -Use a preset TP / SL and/or close if NEXT RSI retraces back to last relevant high or low Target Market: - AAPL 10R Chart - can be used with almost any market; volatility helps Order Management: - Enter on forming divergence, 2 or more clearly separated peaks or troughs - TP / SL at 30 cents (AAPL) - Exit if price retraces to the last NEXT RSI top or bottom referenced when opening the position Optional: - Additional NEXT RSI strategies can be discovered using the free companion NEXT Strategy Visualizer
NASDAQ:AAPLEducation
by ChartVPS
$ISO is giving a GREAT IPO SHORT opportunity todayIPO intraday trading strategy idea IsoPlexis is a company enables deeper access to in vivo biology and drives durable and potentially transformational research on disease in a new era of advanced medicine. The share price is falling and gonna continue this trend today. The demand for shares of the company still looks lower than the supply. These and other conditions can cause a fall in the share price today. So I opened a short position from $13.50; stop-loss — $15.20 take-profit — $8.40/MOC price Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.
IShort
by KozakHlib
CGTX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea Cognition Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $12.87; stop-loss — $11.78; take-profit — $16.14/MOC price. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.
NASDAQ:CGTXLong
by KozakHlib
1
THRX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea Theseus Pharmaceuticals is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $21.40 ; stop-loss — $17.06; take-profit — $34.42/MOC price. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.
TLong
by KozakHlib
EURUSD - Price Action Analysis - H4/H1Reasons for entering on this market structure: - There is an ongoing D1 force on the way down, due to a D1 downtrend plotted in red. This force is supposed to go down for 135pips (2ATR on D1 from the red arrow). Because there is also an ongoing W1 force on the way up, this D1 force will be jeopardized, and will travel 1ATR distance only (current market level) - Price will go to the half mark and will turn up to hit the D1 players SL (1.1970). The D1 SL is also a market structure support/resistance. Regarding the setup for the entry, once the rejection candle on H4 is confirmed, you need to look either for: - a depletion candle on H1 or H2 (candle with long wick closing up) - a engulfing candlestick pattern (upward engulfing, green candle closing above previous red candle high)
Long
by Trade4gammapo
Livent Corp. $LTHMLivent Corp. aktuell mit starkem Momentum und Zug nach Norden. Die Candlesticks zeigen ein starkes Kaufsignal. --> $LTHM Livent Corp. beschäftigt sich mit der Herstellung von Hochleistungs-Lithiumverbindungen. Zu den Produkten gehören Lithiumhydroxid in Batteriequalität, Butyllithium und reines Lithiummetall, die in verschiedenen Leistungsanwendungen verwendet werden. Sie ist in den folgenden geografischen Segmenten tätig: Nordamerika; Europa, Mittlerer Osten und Afrika; Lateinamerika; und Asien-Pazifik. Das Unternehmen wurde am 27. Februar 2018 gegründet und hat seinen Hauptsitz in Philadelphia, PA.
LLong
by TommyTrading
$AVGR can rise in the next daysContextual immersion trading strategy idea. Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1.39; stop-loss — $1.18. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:AVGRLong
by KozakHlib
$IFBD can rise in the next daysContextual immersion trading strategy idea. Infobird Co., Ltd operates as a software-as-a-service (SaaS) provider of artificial intelligence (AI) enabled customer engagement solutions in the People's Republic of China. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $5.07; stop-loss — $3.87. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:IFBDLong
by KozakHlib
4
$GBS can rise in the next daysContextual immersion trading strategy idea. GBS Inc. operates as a biosensor diagnostic technology company. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $4.98; stop-loss — $4.13. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
GLong
by KozakHlib
$ITRM can rise in the next daysContextual immersion trading strategy idea. Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $2.37; stop-loss — $2.10. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:ITRMLong
by KozakHlib
$DARE can rise in the next daysContextual immersion trading strategy idea. Dare Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women's health in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1.68; stop-loss — $1.53. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:DARELong
by KozakHlib
2